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Enabling digital health companionship is better than 
empowerment
In June 2019, WHO and the Organisation for Economic 
Co-operation and Development convened a meeting 
to discuss how best to implement digital health for the 
purpose of transforming health systems, empowering 
individuals, and improving the delivery of high-quality 
health care. This meeting followed the April 2018 
communication1 from the European Commission on 
“enabling the digital transformation of health and 
care in the Digital Single Market; empowering citizens 
and building a healthier society” (appendix). Such 
international calls to action have been effective at 
spreading the message that digital health will bring 
patient empowerment to health-care policy makers 
across the globe. Consequently, empowerment plays a 
prominent role in many national-level policy documents, 
including National Health Service England’s Empower 
the Person strategy (appendix), the eHealth Strategy for 
Ireland, and the National eHealth Strategy of Australia.
The issues with this empowerment narrative are 
varied and covered in more detail elsewhere.2 We are 
primarily concerned with the fact that because these 
strategies largely fail to detail how digital health tools 
(DHTs) empower citizens or patients, governments risk 
using this rhetoric in a potentially deceptive manner. 
The aforementioned strategies seek to encourage the 
adoption of technologies that might make individuals 
responsible for self-surveilling all aspects of their life 
through the digital medical gaze (appendix), instead 
of focusing on how data derived from DHTs can enable 
better care at the level of systems, population, group, or 
individuals. 
This risk of self-surveilling is ethically worrying 
because, as part of this process (the lifestylisation of 
health care;3 appendix), individuals are encouraged 
to reflect on how they might be performing against 
established baselines for health, but not told how these 
baselines were established2 and whether or how far they 
may apply to them. For example, the individual user does 
not know whether their default optimum heart rate 
is actually optimum for a person like them, or only for 
individuals like those included in the design trial (ie, it is 
not clear whether the specific individual fits the profile 
associated with the DHT). The advice provided by DHTs 
promotes conformity rather than autonomy and risks 
undermining individuals’ integrity of self.4
From this more critical perspective, it can be argued that 
DHTs do not promote specific actions and behaviours 
based on objective knowledge (appendix).5 Instead, 
they act as active sociocultural products, promoting 
some norms, lifestyles, and values over others, in a way 
that disciplines (or frustrates and marginalises) those 
with supposedly inferior moral beliefs about health6 
until they meet the standards of the healthy ideal type.5 
This potentially dangerously manipulative process 
reveals what is called empowerment’s correlative vice7 
(appendix), whereby empowerment can feel like an 
elaborate mechanism for victim blaming,5 by creating 
scenarios in which blame for becoming unhealthy or 
sick (which could simply be implied by a seemingly 
anomalous data point) is placed on users for whom it 
would have been difficult, or perhaps even improper, to 
achieve the defined standards of health in the first place.2 
By highlighting this risk, it becomes clear that 
promoting digitally enhanced, empowered health care 
as a techno-utopia is misleading. However, it would also 
be incorrect to present it as a techno-dystopia. At an 
aggregate level, those same seemingly anomalous data 
points identified by empowering DHTs, used to influence 
individuals, can also be used to enable individuals or 
groups (ie, a population, community, or even a family) 
and deliver significant benefits by improving choice of 
access, increasing precise care, lowering the costs of care, 
and enabling better preventative care, and faster and 
more accurate diagnosis. Policy makers are faced with 
the challenge of designing infrastructure that supports 
ethically good outcomes (infraethics) of a responsible 
digital health ecosystem8 that promotes these, and 
other, positive outcomes of DHTs, while avoiding the 
pitfalls. 
Exactly how to do this remains an open question. 
One valuable approach to answering this question is to 
acknowledge that the benefit of DHTs is in their ability 
to help individuals and clinicians to navigate the difficult 
and ever-shifting balance between agency and patiency 
in doctor–patient relationship (ie, whether the individual 
[ie, doctor or patient] is active or passive in the decision 
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making process at any given moment). By acting as 
external repositories for the desires of the individual 
in different circumstances, and storing information 
about their options, wider contexts, and data sharing 
preferences, DHTs can act as volitional aids;9 appendix) 
which ensure the individual’s desire and potential for 
autonomy and agency is respected and enabled,10 rather 
than assuming that they always wish to be empowered.2 
 This shift from empowering to enabling DHTs as 
digital companions2 can help to decrease information 
asymmetry, as it is more likely that relevant, available 
information is accessible by both parties, thus enabling 
the decision to be made by the person who has the 
right to make it. When used in this manner, DHTs can 
provide individuals and groups (eg, a family) with 
a chance to control their desire and potential for 
autonomy, and clinicians with the chance to present 
their recommended advice in a way that respects the 
patients and is interpreted within the context of their 
specific circumstances. 
 To illustrate this point, consider endometriosis, which 
is listed by the National Health Service as being one of 
the most painful conditions to live with. Among women, 
endometriosis is as common as diabetes but takes 
clinicians 7–10 years to diagnose. Research projects like 
Columbia University’s Citizen Endo use DHTs to enable 
patients to record their own personal symptoms (rather 
than those that medical practitioners associate with the 
disease) to discuss with their clinician. These patients 
have not been empowered to take greater control of 
their health by the DHTs, the disease can still only be 
officially diagnosed and treated surgically. However, such 
examples facilitate more information symmetry (at least 
for those with the appropriate level of eHealth literacy), 
enable the sharing and socialisation of information 
and the formations of groups (as opposed to a mere 
clustering in terms of profiling), and thus enhance an 
individual’s autonomy by giving them the opportunity 
to have a more evenly balanced conversation with 
their clinician: one that considers all of their relevant 
personalised information.
Of course, reframing alone will not protect against 
the harms associated with presenting DHTs as a techno-
utopia. However, we wish to stress that, by encouraging 
this positioning, policy makers and health-care system 
designers can provide a more balanced view: one 
that seeks to capitalise on the benefits of DHTs, while 
minimising the risks of potential harms. 
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